Patient Death Triggers FDA Partial Clinical Hold on MacroGenics' LINNET Trial for Gynecologic Cancers
Patient Death Triggers FDA Partial Clinical Hold on MacroGenics' LINNET Trial for Gynecologic Cancers
Posts
FDA places partial clinical hold on Merck and Daiichi Sankyo’s I-DXd lung cancer trial after interstitial lung disease deaths
FDA places partial clinical hold on Merck and Daiichi Sankyo’s I-DXd lung cancer trial after interstitial lung disease deaths
- Get link
- X
- Other Apps